According to the photo I shared, I have a completely bullish view
Digital pharmacy startup Hims & Hers Health ( NYSE:HIMS ) is introducing compounded GLP-1 weight loss injections, which have been gaining popularity due to supply constraints in the market. The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and hair loss, launched a weight loss program in December but did...
#1 DEX on Solana in terms of efficiency and security Wave 4 appears complete at .5 retracement $2.17 estimated ($2.12 actual) Wave 5 Targets: 1.0 $10.47 1.618 $15.62 2.618 $23.95
The prices are at the lows and the structure shows a rejection at low prices and, it´s ready to launch the price to the upside and recover part of its year looses. Good luck!
Weekly timeframe As anticipated the highs were raided even if it was a mere ±40 pips. So what is next? Bullish scenario we may see participants run us all the way to round levels – 40100; 40200; 40300; 40400; 40500 and so and so forth. Where it turns around to sell, I do not know. However, if we do see it sell there are two fair value gaps we can look for a...
A nice and big range to start the week. The points of interest we noted earlier today have all worked pretty nicely. The market moves in ranges and seeks liquidity. Our job as TRADERS is to seek the runs on liquidity and get along with the market. For those who've tape read along the way... a lot of nice opportunities presented themselves for swing...
GRT / USDT Potential breakout ! A confirmed breakout will result in a new bullish wave Put it under your watchlist
💎 Paradisers! Keep your eyes on #OPUSDT as it's showing promising signs of a bullish continuation from the demand zone. 💎 After careful observation of the price action, we’ve noted that $Optimism is on the verge of breaking through descending resistance. If it successfully breaches this resistance and maintains momentum above the EMA 100, there’s a high...
GJ has the potential to push up targeting last month's previous high.
LTO / USDT One of strong coins in in past few weeks We can see it started to show strength again around one of its major support As long as this support hold we can see nice bullish waves in the coming weeks In worst case scenario if this support failed it will drop to 2nd major support in my chart Best of wishes
AudUsd hits a pivot 3month support at price point of 0.87881 and now its going to hit another 3month pivot point of 0.68212 ,soo its going to sell based on this fundamental analysis , hence apply proper risk managemant of 1 percent risk of the capital each trade .
on a daily time frame it is forming inverted head and shoulder, so expecting a good upside move in AWL in upcoming days
Aud Cad is ripe for a sell now it hip a Monthly Pivot of 0.91048 and now it has a 4hrs candle closed below the Pivot point its heading to hit 0.87881 another monthly pivot point , please apply proper risk managemant.
CME: Lean Hog ( CME:HE1! ), Live Cattle ( CME:LE1! ) Here is the official narrative on US inflation: The Federal Reserve’s monetary tightening policy has successfully brought down inflation rate from a four-decade high to about 3 percent, delivering much needed reliefs to US consumers. Government data supports this narrative. Take food costs as an example: In...
Technical Analysis: Gold's recent trading patterns indicate a significant resurgence, touching new highs before retreating to test support levels, indicative of the market's volatile response to global economic signals. The 4-hour chart shows gold peaking at the resistance around $2450 per ounce, signaling a short-term overbought condition which might lead to a...
Technical Analysis: Gold's recent trading patterns indicate a significant resurgence, touching new highs before retreating to test support levels, indicative of the market's volatile response to global economic signals. The 4-hour chart shows gold peaking at the resistance around $2450 per ounce, signaling a short-term overbought condition which might lead to a...
Shah Capital has announced the withdrawal of its campaign against the re-election of three directors on Novavax's board following the COVID-19 vaccine maker's licensing deal with Sanofi. The deal, signed on May 10, entails Sanofi taking a 4.9% stake in Novavax for $70 million at a substantial valuation, including an upfront cash payment of $500 million and future...